Cargando…

Calcium and Magnesium for Oxaliplatin-Induced Neurotoxicity: Issues in Study Design, Measurement, and Analysis

Detalles Bibliográficos
Autor principal:	Visovsky, Constance
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625633/ https://www.ncbi.nlm.nih.gov/pubmed/26557414

Ejemplares similares

The Use of Calcium and Magnesium to Prevent Neurotoxicity in Patients Receiving Oxaliplatin
por: Martyn, Karon, et al.
Publicado: (2015)

Effects of calcium and magnesium on acute and chronic neurotoxicity caused by oxaliplatin: A meta-analysis
por: AO, RUI, et al.
Publicado: (2012)

Phase I drug-interaction study of effects of calcium and magnesium infusions on oxaliplatin pharmacokinetics and acute neurotoxicity in colorectal cancer patients
por: Han, Catherine H, et al.
Publicado: (2013)

Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
por: Argyriou, Andreas A.
Publicado: (2015)

Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2021)

Self-Management of Oxaliplatin-Related Peripheral Neuropathy in Colorectal Cancer Survivors
por: Tofthagen, Cindy, et al.
Publicado: (2013)

Predicting effects on oxaliplatin clearance: in vitro, kinetic and clinical studies of calcium- and magnesium-mediated oxaliplatin degradation
por: Han, Catherine H., et al.
Publicado: (2017)

Acupuncture for the Management of Chemotherapy-Induced Peripheral Neuropathy
por: Visovsky, Constance
Publicado: (2012)

Challenges in the Conduct of Research: Chemotherapy-Induced Peripheral Neuropathy
por: Visovsky, Constance
Publicado: (2013)

Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?
por: Ballarini, Elisa, et al.
Publicado: (2022)

Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity
por: Sałat, Kinga
Publicado: (2020)

Memantine ameliorates oxaliplatin-induced neurotoxicity via mitochondrial protection
por: Wang, Youyu, et al.
Publicado: (2022)

Writing a Successful Grant: Tips and Tools
por: Visovsky, Constance
Publicado: (2015)

Treatment Considerations for the Management of Patients With Hormone Receptor–Positive Metastatic Breast Cancer
por: Visovsky, Constance
Publicado: (2014)

Efficacy of Exercise Rehabilitation Program in Relieving Oxaliplatin Induced Peripheral Neurotoxicity
por: Gui, Qi, et al.
Publicado: (2021)

Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-induced Peripheral Neurotoxicity
por: Nepal, Mahesh R., et al.
Publicado: (2022)

Oxaliplatin-Induced Chronic Peripheral Neurotoxicity: A Prospective Analysis in Patients with Colorectal Cancer
por: Baek, Kyung Kee, et al.
Publicado: (2010)

Antineuropathic Profile of N-Palmitoylethanolamine in a Rat Model of Oxaliplatin-Induced Neurotoxicity
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2015)

The Combination of Zinc and Melatonin Enhanced Neuroprotection and Attenuated Neuropathy in Oxaliplatin-Induced Neurotoxicity
por: Ali, Mayyadah, et al.
Publicado: (2022)

Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies
por: Cheng, Fang, et al.
Publicado: (2023)

A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice
por: Calls, Aina, et al.
Publicado: (2022)

Psychological distress and quality of life in breast cancer survivors with taxane-induced peripheral neuropathy: A scoping review
por: Schwab, Lauren, et al.
Publicado: (2023)

Oxaliplatin neurotoxicity – no general ion channel surface-charge effect
por: Broomand, Amir, et al.
Publicado: (2009)

Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin-induced model of liver injury
por: Zou, Xueqing, et al.
Publicado: (2018)

Oxaliplatin-induced neurotoxicity involves TRPM8 in the mechanism of acute hypersensitivity to cold sensation
por: Kono, Toru, et al.
Publicado: (2012)

The Challenges of Clinical Research in Rare Cancers: Bevacizumab Use in Low-Grade Serous Ovarian and Primary Peritoneal Cancers
por: Grande, Carolyn, et al.
Publicado: (2017)

Dose Effects of Oxaliplatin on Persistent and Transient Na(+) Conductances and the Development of Neurotoxicity
por: Park, Susanna B., et al.
Publicado: (2011)

Critical Issues in the Study of Magnesium Transport Systems and Magnesium Deficiency Symptoms in Plants
por: Kobayashi, Natsuko I., et al.
Publicado: (2015)

Aqueous extract of Lithospermi radix attenuates oxaliplatin-induced neurotoxicity in both in vitro and in vivo models
por: Cho, Eun-Sang, et al.
Publicado: (2016)

The Incidence of Oxaliplatin-Induced Peripheral Neurotoxicity at Khartoum Oncology Hospital: A Cross-Sectional Survey
por: Ali, Nadeen T., et al.
Publicado: (2020)

Ameliorative effects of aqueous extract of Forsythiae suspensa fruits on oxaliplatin-induced neurotoxicity in vitro and in vivo
por: Yi, Jin-Mu, et al.
Publicado: (2019)

Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity
por: Branca, Jacopo Junio Valerio, et al.
Publicado: (2018)

STUDIES ON CALCIUM AND MAGNESIUM METABOLISM IN DISEASE : I. CALCIUM AND MAGNESIUM METABOLISM IN LEPROSY.
por: Underhill, Frank P., et al.
Publicado: (1920)

Developmental Neurotoxicity: Some Old and New Issues
por: Giordano, Gennaro, et al.
Publicado: (2012)

Efficacy of Traditional Chinese Medicine Injection in Preventing Oxaliplatin-Induced Peripheral Neurotoxicity: An Analysis of Evidence from 3598 Patients
por: Chen, Zhi-Ying, et al.
Publicado: (2022)

Stereoselective peripheral sensory neurotoxicity of diaminocyclohexane platinum enantiomers related to ormaplatin and oxaliplatin.
por: Screnci, D., et al.
Publicado: (1997)

Efficacy of Goshajinkigan for Peripheral Neurotoxicity of Oxaliplatin in Patients with Advanced or Recurrent Colorectal Cancer
por: Kono, Toru, et al.
Publicado: (2011)

Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights
por: Marmiroli, Paola, et al.
Publicado: (2017)

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy
por: Kono, Toru, et al.
Publicado: (2013)

Peripheral Neuropathy Caused by Paclitaxel and Docetaxel: An Evaluation and Comparison of Symptoms
por: Tofthagen*, Cindy, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ihul15hgth1h3cgm5b7fovdl5c